Diabetic sclerodactyly is a frequently recognized skin finding that may occur in patients with diabetes mellitus but coexistence of diabetes and systemic sclerosis is rare. We describe a case of coexistence of type 1 diabetes mellitus and systemic sclerosis in 42-year-old man with the history of Raynaud's phenomenon, progressive diffuse hardening of the skin and sclerodactyly, slowly worsening ...

1 Graf M W, Uhr J W. Regulation of antibody formation by serum antibody. I. Removal of specific antibody by means of immunoadsorption. Exp Med 1969; 130: 1175-86. 2 Bystryn J C, Graf M W, Uhr J W. Regulation of antibody formation by serum antibody. II. Removal of specific antibody by means of exchange transfusion. Exp Med 1970; 132: 1279-87. 3 Verrier Jones J, Robinson M F, Parciany R K, Layfer...

UNLABELLED Systemic sclerosis (SSc) is a chronic autoimmune disease connective tissue and one of the most common collagen diseases. There are several clinical types of scleroderma which differ in their course, possible complications and prognosis. The most characteristic form SSc is limited and diffuse systemic sclerosis. The SSc is characterized by the progressive fibrosis of the skin and inte...

INTRODUCTION S ystemic sclerosis (scleroderma) is an autoimmune disorder of unclear etiology that leads to fibrosis and vascular injury of the skin and multiple organs, including the lungs, heart, gastrointestinal tract, kidneys, and the musculoskeletal system. It is classified as either diffuse or limited cutaneous based on the extent of skin thickening. In the diffuse form of systemic scleros...

Systemic sclerosis (SSc) is a multisystem connective tissue disease of unknown etiology. Similar to other connective tissue diseases, SSc follows a chronic course, occurs more commonly in women, and is highly heterogeneous in its protean clinical manifestations. The hallmarks of SSc are autoimmunity and inflammation, functional and structural abnormalities in small blood vessels in multiple vas...

Aim: Multiple sclerosis (MS) is one of the most common chronic progressive neurological diseases and is regarded as the non-traumatic cause of neurological disability in youth. The Multiple sclerosis patients need for family caregiver increasingly grows due to the progressive course of the disease, which worsens the symptoms over time. Family caregivers of this group of patients are subject to ...

Systemic sclerosis is a chronic, progressive disease with an extremely poor prognosis. The incidence of malignant tumors in patients with systemic sclerosis is increased when compared with that of the general population. In certain malignancies, systemic sclerosis presents as a paraneoplastic process. The symptoms of sclerosis in the organs of the head and neck often overlap with symptoms of ma...

conclusions this study indicated that the rv systolic strain and strain rate can be used to detect early rv systolic dysfunction in ssc patients without pulmonary hypertension. these parameters may be useful for the provision of a more adequate management of ssc patients. results in the ssc patients, the rv strain (- 19 ± 10 vs. - 25 ± 4 %; p = 0.004) and the systolic strain rate (- 1.3 ± 0.5 v...

Numerous systemic diseases share immunopathogenic mechanisms. This article reviews the proposed etiologies and immunopathogenic mechanisms of a group of diseases which share pulmonary and renal abnormalities. Specifically, we discuss the following diseases: Good-pasture's syndrome, systemic lupus erythematosus, progressive systemic sclerosis, Wegener's granulomatosis, lymphomatoid granulomatosi...

An association between one of the collagen diseases, dermatomyositis, and malignant disease is well recognized; in a recent review Caldwell (1955) states that there are nearly 70 reported cases in which the association has been noted, and an incidence of 18 % malignancy in cases of dermatomyositis has been reported by Curtis, Blaylock, and Harrell (1952). Many authorities (Dowling, 1940; Freude...